RWM
CVS icon

Rench Wealth Management’s CVS Health CVS Stock Holding History

Rench Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,352
Closed -$5.48M – 49
2023
Q4 		$5.48M Sell
69,352
-3,830
-5% -$273K 2.31% 18
2023
Q3 		$5.11M Buy
73,182
+395
+0.5% +$28K 2.35% 17
2023
Q2 		$5.03M Buy
72,787
+2,284
+3% +$163K 2.21% 19
2023
Q1 		$5.24M Buy
70,503
+1,568
+2% +$131K 2.51% 15
2022
Q4 		$6.42M Buy
68,935
+26
+0% +$2.51K 3.27% 10
2022
Q3 		$6.57M Sell
68,909
-156
-0.2% -$15.4K 3.69% 6
2022
Q2 		$6.4M Buy
69,065
+750
+1% +$73.2K 3.28% 9
2022
Q1 		$6.91M Sell
68,315
-4,797
-7% -$504K 3.14% 11
2021
Q4 		$7.54M Sell
73,112
-982
-1% -$90.7K 3.4% 12
2021
Q3 		$6.29M Sell
74,094
-57
-0.1% -$4.77K 3.12% 12
2021
Q2 		$6.19M Sell
74,151
-200
-0.3% -$16.4K 3.09% 14
2021
Q1 		$5.59M Buy
74,351
+2,200
+3% +$160K 2.91% 15
2020
Q4 		$4.93M Buy
72,151
+2,903
+4% +$189K 2.77% 17
2020
Q3 		$4.04M Buy
69,248
+904
+1% +$56.3K 2.57% 19
2020
Q2 		$4.44M Sell
68,344
-131
-0.2% -$8.25K 2.99% 16
2020
Q1 		$4.06M Buy
68,475
+508
+0.7% +$33.9K 3.16% 14
2019
Q4 		$5.05M Buy
67,967
+28,187
+71% +$1.98M 2.91% 15
2019
Q3 		$2.51M Buy
39,780
+3,857
+11% +$229K 1.62% 34
2019
Q2 		$1.96M Buy
35,923
+1,987
+6% +$107K 1.25% 37
2019
Q1 		$1.83M Buy
33,936
+1,932
+6% +$119K 1.2% 37
2018
Q4 		$2.1M Buy
32,004
+624
+2% +$46.6K 1.54% 34
2018
Q3 		$2.47M Buy
31,380
+2,728
+10% +$195K 1.65% 34
2018
Q2 		$1.84M Buy
28,652
+686
+2% +$45.2K 1.33% 38
2018
Q1 		$1.74M Buy
27,966
+455
+2% +$32.6K 1.19% 40
2017
Q4 		$2M Buy
27,511
+11,743
+74% +$854K 1.3% 40
2017
Q3 		$1.28M Buy
+15,768
New +$1.25M 0.88% 41

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rench Wealth Management's CVS Position: Q1 2024 in Review

Rench Wealth Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 69,352 shares — an estimated $5.48M sold.

Rench Wealth Management first reported a position in CVS in Q3 2017 and held it in 26 quarters. The position peaked at $7.54M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Rench Wealth Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Rench Wealth Management sold 69,352 CVS Health shares in Q1 2024, an estimated $5.48M.
  • Rench Wealth Management first reported a position in CVS Health in Q3 2017 and held it in 26 quarters.
  • Rench Wealth Management's CVS Health position peaked at $7.54M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Rench Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.